Pharmacological treatment of ocular inflammatory diseases

Novel strategies for ocular anti-inflammatory therapies are extensively being investigated to increase drug bioavailability and decrease adverse side effects of common treatments.

Colloidal carriers based on lipid materials are becoming a suitable alternative due to several advantages, including solubilisation of hydrophobic/lipophilic anti-inflammatory drugs followed by bioavailability enhancement, modification of pharmacokinetic parameters, and protection of sensitive drugs from physical, chemical or biological degradation.

This book presents and discusses data on the improvements being made in regards to novel drug delivery systems.